Markets
News
Analysis
User
24/7
Economic Calendar
Education
Data
- Names
- Latest
- Prev












Signal Accounts for Members
All Signal Accounts
All Contests



U.S. U6 Unemployment Rate (SA) (Nov)A:--
F: --
P: --
U.S. Average Hourly Wage MoM (SA) (Oct)A:--
F: --
P: --
U.S. Average Hourly Wage YoY (Oct)A:--
F: --
P: --
U.S. Retail Sales (Oct)A:--
F: --
P: --
U.S. Core Retail Sales MoM (Oct)A:--
F: --
U.S. Core Retail Sales (Oct)A:--
F: --
P: --
U.S. Retail Sales MoM (Oct)A:--
F: --
U.S. Private Nonfarm Payrolls (SA) (Oct)A:--
F: --
U.S. Average Weekly Working Hours (SA) (Oct)A:--
F: --
P: --
U.S. Labor Force Participation Rate (SA) (Nov)A:--
F: --
P: --
U.S. Retail Sales YoY (Oct)A:--
F: --
P: --
U.S. Manufacturing Employment (SA) (Oct)A:--
F: --
U.S. Government Employment (Nov)A:--
F: --
P: --
U.S. Weekly Redbook Index YoYA:--
F: --
P: --
U.S. IHS Markit Manufacturing PMI Prelim (SA) (Dec)A:--
F: --
P: --
U.S. IHS Markit Composite PMI Prelim (SA) (Dec)A:--
F: --
P: --
U.S. IHS Markit Services PMI Prelim (SA) (Dec)A:--
F: --
P: --
U.S. Commercial Inventory MoM (Sept)A:--
F: --
P: --
BOC Gov Macklem Speaks
Argentina GDP YoY (Constant Prices) (Q3)A:--
F: --
P: --
U.S. API Weekly Gasoline StocksA:--
F: --
P: --
U.S. API Weekly Cushing Crude Oil StocksA:--
F: --
P: --
U.S. API Weekly Refined Oil StocksA:--
F: --
P: --
U.S. API Weekly Crude Oil StocksA:--
F: --
P: --
Australia Westpac Leading Index MoM (Nov)A:--
F: --
Japan Trade Balance (Not SA) (Nov)A:--
F: --
P: --
Japan Goods Trade Balance (SA) (Nov)A:--
F: --
P: --
Japan Imports YoY (Nov)A:--
F: --
P: --
Japan Exports YoY (Nov)A:--
F: --
P: --
Japan Core Machinery Orders YoY (Oct)A:--
F: --
P: --
Japan Core Machinery Orders MoM (Oct)A:--
F: --
P: --
U.K. Core CPI MoM (Nov)--
F: --
P: --
U.K. Inflation Rate Expectations--
F: --
P: --
U.K. Core Retail Prices Index YoY (Nov)--
F: --
P: --
U.K. Core CPI YoY (Nov)--
F: --
P: --
U.K. Output PPI MoM (Not SA) (Nov)--
F: --
P: --
U.K. Output PPI YoY (Not SA) (Nov)--
F: --
P: --
U.K. Input PPI YoY (Not SA) (Nov)--
F: --
P: --
U.K. CPI YoY (Nov)--
F: --
P: --
U.K. Retail Prices Index MoM (Nov)--
F: --
P: --
U.K. CPI MoM (Nov)--
F: --
P: --
U.K. Input PPI MoM (Not SA) (Nov)--
F: --
P: --
U.K. Retail Prices Index YoY (Nov)--
F: --
P: --
Indonesia 7-Day Reverse Repo Rate--
F: --
P: --
Indonesia Deposit Facility Rate (Dec)--
F: --
P: --
Indonesia Lending Facility Rate (Dec)--
F: --
P: --
Indonesia Loan Growth YoY (Nov)--
F: --
P: --
South Africa Core CPI YoY (Nov)--
F: --
P: --
South Africa CPI YoY (Nov)--
F: --
P: --
Germany Ifo Business Expectations Index (SA) (Dec)--
F: --
P: --
Germany Ifo Current Business Situation Index (SA) (Dec)--
F: --
P: --
Germany IFO Business Climate Index (SA) (Dec)--
F: --
P: --
Euro Zone Core CPI Final MoM (Nov)--
F: --
P: --
Euro Zone Labor Cost YoY (Q3)--
F: --
P: --
Euro Zone Core HICP Final YoY (Nov)--
F: --
P: --
Euro Zone Core HICP Final MoM (Nov)A:--
F: --
P: --


No matching data
Latest Views
Latest Views
Trending Topics
Top Columnists
Latest Update
White Label
Data API
Web Plug-ins
Affiliate Program
View All

No data
By Colin Kellaher
Enliven Therapeutics has hired Rick Fair to replace co-founder Sam Kintz as president and chief executive of the clinical-stage biopharmaceutical company.
Enliven on Thursday said Kintz, who has been at the helm of the Boulder, Colo., company since 2019, is assuming a new role as head of pipeline.
Fair, 57 years old, most recently served as president and CEO of clinical-stage biopharmaceutical company Bellicum Pharmaceuticals.
Enliven said Fair will receive an annual base salary of $660,000 and an annual bonus with a target of 55% of his base pay, adding that he will also succeed Kintz as a member of the board.
Write to Colin Kellaher at colin.kellaher@wsj.com
White Label
Data API
Web Plug-ins
Poster Maker
Affiliate Program
The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.
No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.
Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.
Not Logged In
Log in to access more features

FastBull Membership
Not yet
Purchase
Log In
Sign Up